Published on
Monday, March 5, 2012
Edmond de Rothschild
Investment Partners has determined
that bigger is better and thus is out raising a €200
million ($268.5 million) fourth life sciences venture fund that will be larger
than its €156 million ($242.9 million) BioDiscovery 3 fund that
closed in 2008.
Gilles Nobecourt of EdRIP told
BioCentury that it would have been better if BioDiscovery 3 had had a couple of
more portfolio companies, with slightly more allocated per investment. The firm
has made 15 investments from BioDiscovery 3 and Nobecourt said it might do one